ResearcherCentre National de la Recherche ScientifiqueNo recent work listed
Patrick Couvreur
Matched on ORCID iD 0000-0001-7961-5443; OpenAlex author ID A5078174247. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: 1 paper
Papers 5
- Dual controlled delivery of squalenoyl-gemcitabine and paclitaxel using thermo-responsive polymeric micelles for pancreatic cancer. Co-author DOI 10.1039/c7tb02899g↗
- Desmoplastic Reaction in 3D-Pancreatic Cancer Tissues Suppresses Molecular Permeability. Co-author DOI 10.1002/adhm.201700057↗
- Lipid-Conjugation of Endogenous Neuropeptides: Improved Biotherapy against Human Pancreatic Cancer. Last author DOI 10.1002/adhm.201400816↗
- Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies. Last author DOI 10.1016/j.ijpharm.2014.11.009↗
- Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer. Co-author DOI 10.1016/j.nano.2011.02.012↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Simona Mura · 2 shared papers, 2015–2017 · strength 0.14
- Andrei Maksimenko · 2 shared papers, 2015 · strength 0.12
- Mandana Emamzadeh · 1 shared paper, 2018 · strength 0.12
- George Pasparakis · 1 shared paper, 2018 · strength 0.12
- Mitsuru Akashi · 1 shared paper, 2017 · strength 0.08
- Hiroyoshi Y. Tanaka · 1 shared paper, 2017 · strength 0.08
- Mitsunobu R. Kano · 1 shared paper, 2017 · strength 0.08
- Michiya Matsusaki · 1 shared paper, 2017 · strength 0.08
- Gopakumar Gopalakrishnan · 1 shared paper, 2015 · strength 0.06
- Soukaina Réjiba · 1 shared paper, 2011 · strength 0.03
- Amor Hajri · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.